Aura Biosciences (AURA) Change in Acquisitions & Divestments (2022 - 2026)

Aura Biosciences (AURA) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $55.0 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 83.33% year-over-year to $55.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $145.0 million (down 8.91% YoY) and the FY2025 annual result came in at $120.0 million, down 7.11% from the prior year.
• Change in Acquisitions & Divestments rose to $55.0 million in Q1 2026, from $30.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $99.2 million in Q3 2024 to a low of $18.0 million in Q3 2022.
• A 5-year average of $36.5 million and a median of $30.0 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments surged 356.66% — and 2025, when it sank 69.75%.
• Tracing AURA's Change in Acquisitions & Divestments over 5 years: stood at $32.0 million in 2022, then soared by 71.83% to $55.0 million in 2023, then tumbled by 45.46% to $30.0 million in 2024, then increased by 0.0% to $30.0 million in 2025, then surged by 83.33% to $55.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $55.0 million (Q1 2026), $30.0 million (Q4 2025), and $30.0 million (Q3 2025), per Business Quant data.